NCT01941641View on ClinicalTrials.gov

Colon Neoadjuvant FOLFOXIRI Study

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

October 9, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Rectal Cancer

Interventions

DRUG

neoadjuvant FOLFOXIRI

DRUG

Capecitabine

Trial Locations (1)

Unknown

Department of Clinical Oncology, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER